Allison Armstrong

Allison Armstrong

Company: HemoShear

Job title: Senior Scientific Director, Rare Disease Programs


Dr. Armstrong is the project team leader for the Propionic and Methylmalonic Acidemia (PA and MMA) drug discovery programs at HemoShear Therapeutics.  She is responsible for aligning the integrated development plan in coordination with senior functional leaders, supporting development of regulatory documents, and representing the program status, scenarios and direction with senior leadership.


Session Q&A 12:00 pm

Ask the expert speakers from this session all your burning questionsRead more

day: Day Two

From Bench to Bedside: An Unconventional Approach from Biomarker Validation to Phase II Clinical Studies in Metabolic Rare Diseases 11:40 am

• Developing human surrogate disease models with patient cells for drug discovery and development • Propionic and Methylmalonic Acidemia – Demonstrating HST5040 efficacy using biomarkers in human surrogate disease models • Evaluating meaningful biomarkers and exploring registrable endpoints – from bench to bedsideRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.